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abstract
 
A number of peptide toxins from venoms of spiders and cone snails are high afﬁnity ligands for volt-
age-gated calcium channels and are useful tools for studying calcium channel function and structure. Using whole-
cell recordings from rat sympathetic ganglion and cerebellar Purkinje neurons, we studied toxins that target neu-
 
ronal N-type (Ca
 
V
 
2.2) and P-type (Ca
 
V
 
2.1) calcium channels. We asked whether different toxins targeting the same
 
channels bind to the same or different sites on the channel. Five toxins (
 
 
 
-conotoxin-GVIA, 
 
 
 
-conotoxin MVIIC,
 
 
 
-agatoxin-IIIA, 
 
 
 
-grammotoxin-SIA, and 
 
 
 
-agatoxin-IVA) were applied in pairwise combinations to either N- or
 
P-type channels. Differences in the characteristics of inhibition, including voltage dependence, reversal kinetics, and
fractional inhibition of current, were used to detect additive or mutually occlusive effects of toxins. Results suggest
at least two distinct toxin binding sites on the N-type channel and three on the P-type channel. On N-type channels,
 
results are consistent with blockade of the channel pore by 
 
 
 
-CgTx-GVIA, 
 
 
 
-Aga-IIIA, and 
 
 
 
-CTx-MVIIC, whereas
grammotoxin likely binds to a separate region coupled to channel gating. 
 
 
 
-Aga-IIIA produces partial channel
block by decreasing single-channel conductance. On P-type channels, 
 
 
 
-CTx-MVIIC and 
 
 
 
-Aga-IIIA both likely
bind near the mouth of the pore. 
 
 
 
-Aga-IVA and grammotoxin each bind to distinct regions associated with chan-
nel gating that do not overlap with the binding region of pore blockers. For both N- and P-type channels, 
 
 
 
-CTx-
MVIIC binding produces complete channel block, but is prevented by previous partial channel block by 
 
 
 
-Aga-IIIA,
suggesting that 
 
 
 
-CTx-MVIIC binds closer to the external mouth of the pore than does 
 
 
 
-Aga-IIIA.
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INTRODUCTION
 
Voltage-gated calcium channels are divided into sub-
types based on biophysical or pharmacological proper-
ties and on the diversity of genes encoding functional
channels (Hofmann et al., 1994; Dunlap et al., 1995;
Mori et al., 1996; Perez-Reyes et al., 1998). Several lines
of evidence indicate separate cellular roles for different
calcium channel subtypes (Deisseroth et al., 1998; Mar-
rion and Tavalin, 1998; Graef et al., 1999; Sutton et al.,
1999). Some of the most useful reagents to distinguish
among different calcium channel subtypes are peptides
isolated from the venom of spiders or cone snails; such
peptides can inhibit current through speciﬁc channel
subtypes with nanomolar potency (Adams et al., 1990;
Olivera et al., 1990; Adams and Olivera, 1994; Olivera,
1997). As calcium channels are current or potential tar-
gets for therapeutics directed against migraine (Ophoff
et al., 1996), intractable pain (Bowersox and Luther,
1998), some forms of epilepsy (Burgess et al., 1997; Hu-
guenard, 1999), and ataxia (Zhuchenko et al., 1997;
Lorenzon et al., 1998; Wakamori et al., 1998; Jun et al.,
1999), toxin–channel pharmacology is interesting from
both scientiﬁc and clinical perspectives.
 
In this study, we investigate interactions of sev-
 
eral toxins with native neuronal N- and P-type cal-
 
cium channels. N-type channels, formed by the 
 
 
 
1B
(CaV2.2) gene product, are inhibited speciﬁcally by the
cone snail venom component 
 
 
 
-conotoxin-GVIA (Oli-
vera et al., 1984; McCleskey et al., 1987; Aosaki and Ka-
sai, 1989). P-type channels from cerebellar Purkinje
neurons, likely a splice variant of the 
 
 
 
1A (CaV2.1)
gene product (Gillard et al., 1997; Jun et al., 1999; Bou-
rinet et al., 1999; Hans et al., 1999), are inhibited selec-
tively by the spider toxin 
 
 
 
-Aga-IVA (Mintz et al.,
1992a,b; Venema et al., 1992). Several other toxins (
 
 
 
-
grammotoxin-SIA, 
 
 
 
-conotoxin-MVIIC, and 
 
 
 
-Aga-IIIA,
from tarantula, cone snail, and spider venom, respec-
tively) inhibit both N- and P-type channels potently
(Mintz et al., 1991; Venema et al., 1992; Hillyard et al.,
1992; Lampe et al., 1993). A given channel may have
multiple binding sites for different toxins, or several
different toxins may target the same binding site. To
address this issue, we used electrophysiological mea-
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surements of current through N- and P-type channels
to characterize the effects of saturating toxin concen-
trations applied sequentially or cumulatively. Differ-
ences in reversibility, voltage dependence, and com-
pleteness of maximal block allowed us to determine
whether or not toxins could bind simultaneously to the
same channel. The results suggest at least two different
extracellular toxin binding sites on the N-type calcium
channel and three on the P-type calcium channel.
 
MATERIALS AND METHODS
 
Cell Preparation
 
Purkinje neurons were isolated from the brains of 8–16-d-old
Long-Evans rats as described previously (Mintz et al., 1992a; Mc-
Donough et al., 1997b). Sympathetic neurons were isolated from
superior cervical ganglia (SCG)* of 12–21-d-old rats (Boland et
al., 1994). Neurons were used within 8 h of dissociation.
 
Electrophysiological Methods
 
Currents through voltage-activated calcium channels were re-
corded using the whole-cell conﬁguration of the patch-clamp
technique (Hamill et al., 1981). Patch pipettes were made from
borosilicate glass tubing (Boralex; Dynalab), coated with Sylgard
(Dow Corning Corp.), and sometimes ﬁre-polished. Pipettes had
resistances of 0.5–2 M
 
 
 
 when ﬁlled with internal solution. After
establishment of the whole-cell recording conﬁguration, the cell
was lifted off the bottom of the dish and positioned in front of an
array of 12 perfusion tubes made of 250 
 
 
 
m internal diameter
quartz tubing connected by Teﬂon tubing to glass reservoirs.
Currents were recorded with an Axopatch 200A ampliﬁer
(Axon Instruments, Inc.), ﬁltered with a corner frequency of 5
kHz (4-pole Bessel ﬁlter), digitized (10 kHz) using a Digidata
1200 interface and pClamp6 software (Axon Instruments, Inc.),
and stored on a computer. Compensation (typically 80–95%) for
series resistance (typically 
 
 
 
2.5 times higher than the pipette re-
sistance) was used. Only data from cells with remaining uncom-
pensated series resistance and current small enough to give a
voltage error of 
 
 
 
5 mV were analyzed. Calcium channel currents
were corrected for leak and capacitative currents, either by apply-
ing CdCl
 
2
 
 to block Ca channel current or by subtracting a scaled
current elicited by a 10-mV hyperpolarization from 
 
 
 
80 mV.
 
Solutions
 
Before recording, cells were bathed in the recording chamber
with Tyrode’s solution, consisting of 150 mM NaCl, 4 mM KCl, 2
mM CaCl
 
2
 
, 2 mM MgCl
 
2
 
, 10 mM HEPES, and 10 mM glucose, pH
7.4 with NaOH. Currents through calcium channels were re-
corded using 2–5 mM Ba
 
2
 
 
 
 as charge carrier and using Cs
 
 
 
-based
internal solutions, allowing resolution of outward currents car-
ried by Cs
 
 
 
 through the calcium channels. The standard pipette
solution for Purkinje neurons contained 56 mM CsCl, 68 mM
CsF, 2.2 mM MgCl
 
2
 
, 4.5 mM EGTA, 9 mM HEPES, 4 mM MgATP,
14 mM creatine phosphate (Tris salt), and 0.3 mM GTP (Tris
salt), pH 7.4 adjusted with CsOH. The pipette solutions for sym-
pathetic neurons were similar but used various combinations of
chloride, phosphate, and glutamate as the primary anions. The
standard external solution for Purkinje neurons contained 2 mM
BaCl
 
2
 
, 160 mM TEACl, 10 mM HEPES, pH 7.4 with TEAOH, with
 
0.6 
 
 
 
M tetrodotoxin to block outward Cs currents through Na
channels, 5 
 
 
 
M nimodipine to block L-type calcium channels, 1
 
 
 
M 
 
 
 
-conotoxin GVIA to block N-type calcium channels, and 1
mg/ml cytochrome C to minimize adsorption of toxins to reser-
voirs or tubing. Experiments on rat sympathetic neurons used
similar solutions but omitted 
 
 
 
-conotoxin GVIA and used 5 mM
BaCl
 
2
 
 in the external recording solution. Exact compositions of
internal and external solutions for each experimental series are
noted in the ﬁgure legends.
To apply toxins, external solutions were exchanged in 
 
 
 
1 s by
moving the cell between continuously ﬂowing solutions from the
perfusion tubes. Voltages are uncorrected for liquid junction po-
tentials between the pipette solution and the Tyrode’s solution in
which the offset potential was zeroed before seal formation. Junc-
tion potentials were 
 
 
 
13 mV for the cesium phosphate internal
solution and 
 
 
 
2 mV for the cesium ﬂuoride/cesium chloride in-
ternal solution. To improve the resolution of tail current kinetics,
some experiments were done at 10–12
 
 
 
C, with the chamber
cooled by circulating 3
 
 
 
C water through copper tubing that
cooled a copper plate under the chamber. Temperature was mea-
sured using a thermistor in the bath.
Statistics are given as mean 
 
 
 
 SEM.
 
Toxins
 
The text below (and see Table I) summarizes previous knowl-
edge about the channel speciﬁcity and mode of action of the tox-
ins that we studied.
 
 
 
-
 
Conotoxin
 
-
 
GVIA (CgTx) is a 27–amino acid peptide, origi-
nally isolated from the venom of the cone snail 
 
Conus geographus
 
(Olivera et al., 1984), that blocks expressed channels containing
the 
 
 
 
1B
 
 subunit. Block by CgTx deﬁnes “N-type” native channels
pharmacologically (Feldman et al., 1987; McCleskey et al., 1987;
Fujita et al., 1993;
 
 
 
Williams et al., 1992). Channels bound to
CgTx do not pass current at any voltage; CgTx blocks irreversibly
on the time scale of an electrophysiological experiment (Boland
et al., 1994).
 
 
 
-Conotoxin-MVIIC (
 
 
 
-CTx-MVIIC) is a 26–amino acid toxin
from 
 
Conus magus
 
 venom, cloned by its homology to CgTx, that
blocks N- and P-type calcium channels (Hillyard et al., 1992).
Like CgTx, application of 
 
 
 
-CTx-MVIIC eliminates inward cur-
rent, outward current, and the inward tail current evoked by de-
polarizations up to 
 
 
 
150 mV. However, unlike 
 
 
 
-CgTx-GVIA, the
reversal of 
 
 
 
-CTx-MVIIC inhibition of N-type channels is rapid
(k
 
off
 
 
 
 
 
0.04 s
 
 
 
1
 
). Inhibition of P-type channels by 
 
 
 
-CTx-MVIIC is
slow and essentially irreversible (McDonough et al., 1996).
 
 
 
-Grammotoxin-SIA (GTx) is a 36–amino acid peptide from
the venom of the Chilean tarantula 
 
Grammostola spatulata
 
 or 
 
Phrix-
otrichus spatulata
 
 (Lampe et al., 1993). Concentrations 
 
 
 
50 nM in-
hibit all inward current through N- and P-type channels due to a
depolarizing shift in the voltage dependence of gating; sufﬁ-
ciently strong depolarizations will open channels bound to toxin
(Piser et al., 1995; McDonough et al., 1997a; Bourinet et al.,
2001). The GTx off-rate at the lowered temperatures (10
 
 
 
C) is es-
sentially zero, even with repeated strong depolarizations.
 
 
 
-Agatoxin-IVA (
 
 
 
-Aga-IVA), a 48–amino acid protein from
the venom of the funnel web spider 
 
Agelenopsis aperta
 
, inhibits
current through P-type, but not through N-type or L-type, chan-
nels at nanomolar concentrations (Mintz et al., 1992a,b; Bargas
et al., 1994; Eliot and Johnston, 1994; Wu and Saggau, 1994; Mag-
nelli et al., 1995; Randall and Tsien, 1995). 
 
 
 
-Aga-IVA inhibits
current through calcium channels formed by some, but not all,
isoforms of the 
 
 
 
1A subunit; toxin potency also is affected by the
expression system (Bourinet et al., 1999). Like GTx, 
 
 
 
-Aga-IVA
inhibits inward current by increasing the voltage required to acti-
vate the channel. The off-rate of 
 
 
 
-Aga-IVA from the calcium
 
*
 
Abbreviation used in this paper:
 
 SCG, superior cervical ganglia. 
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channels of Purkinje neurons is essentially zero with depolariza-
tions less than 
 
 
 
50 mV (McDonough et al., 1997b).
 
 
 
-Agatoxin-IIIA (
 
 
 
-Aga-IIIA), a 76–amino acid protein from
the venom of 
 
Agelenopsis aperta
 
 (Venema et al., 1992; Yan and Ad-
ams, 2000), is the most potent calcium channel ligand known,
with half-maximal blocking concentration of 
 
 
 
1 nM for L-type as
well as N- and P-type channels. Maximal inhibition by 
 
 
 
-Aga-IIIA
abolishes current through L-type channels, but inhibits inward
current through N- or P-type channels only partially (
 
 
 
70%;
Mintz et al., 1991; Mintz, 1994). The 
 
 
 
-Aga-IIIA off-rate is negligi-
ble within tens of minutes.
Toxins were stored at 
 
 
 
20
 
 
 
C in water and diluted in the exter-
nal solution the day of the experiment. Synthetic GTx, 
 
 
 
-Aga-
IVA, and puriﬁed 
 
 
 
-Aga-IIIA were gifts of Dr. Richard Keith (Zen-
eca Pharmaceuticals, Wilmington, DE), Dr. Nicholas Saccomano
(Pﬁzer, Inc., Groton, CT), and Dr. Michael Adams (University of
California, Riverside), respectively. 
 
 
 
-Aga-IIIA powder was added
directly to external recording solution. Synthetic 
 
 
 
-CTx-MVIIC
and CgTx were obtained from Bachem or from Peninsula Pep-
tides. Toxins were occasionally used the day after dilution into
external solution with no detectable loss of potency.
 
RESULTS
 
N-type Channels
CgTx and GTx:
 
The experiment shown in Fig. 1 tested
whether GTx binding to N-type calcium channels pre-
vents binding of CgTx. This test is made possible by a dif-
ference in the characteristics of inhibition by the two
toxins. With saturating concentrations of GTx, current
activated by moderate depolarizations is almost com-
pletely blocked, but channels can still be activated by suf-
ﬁciently large depolarizations (McDonough et al.,
1997a). In contrast, CgTx blocks current through N-type
channels at all voltages (Boland et al., 1994). The exper-
iment was performed using a rat sympathetic neuron us-
ing solutions containing nimodipine to block L-type
channels, so that the great majority of the remaining
current is N-type current. In control (Fig. 1, top left), de-
Figure 1. CgTx blocks
N-type channels that have al-
ready bound GTx. N-type cur-
rents were recorded from a
rat sympathetic neuron with
an external solution contain-
ing 5  M nimodipine to
block L-type channels. (top)
Currents were evoked by 20-
ms depolarizations to  20
and  150 mV from a holding
potential of  70 mV, with tail
currents elicited at  50 mV.
Bottom graphs plot peak cur-
rent during a 20-ms depolar-
izations to the indicated test
voltage (left) or peak tail cur-
rent at  50 mV after the test
pulse (right). Open circles,
control; closed circles,  500
nM GTx; open squares,
GTx   1  M CgTx. The volt-
age pulse protocol given in the
presence of GTx did not re-
sult in signiﬁcant dissociation
of GTx from the channel (as-
sayed by a step to  20 mV af-
ter the protocol). Records in
GTx   CgTx were taken start-
ing 75 s after ﬁrst addition of
CgTx, in the continual pres-
ence of GTx. External solu-
tion: 5 mM BaCl2, 160 mM
TEACl, 10 mM HEPES, pH
7.4 with TEAOH, 5  M nimo-
dipine, and 1 mg/ml cyto-
chrome C. Internal solution
(in mM): 210 CsOH, 10 CsCl,
10 HEPES, 10 CsEGTA, 14
creatine phosphate (Tris
salt), 4 Mg-ATP, and 0.4 GTP
(Tris salt), pH 7.4 with
H3PO4. 22 C. 
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polarization to 
 
 
 
20 mV evoked an inward current, car-
ried by extracellular barium, and depolarization to 
 
 
 
150
mV evoked an outward current, carried by intracellular
cesium. A saturating concentration of GTx (500 nM; Fig.
1 top, middle) inhibited virtually all the current evoked
by the pulse to 
 
 
 
20 mV, whereas the pulse to 
 
 
 
150 mV
evoked slowly activating outward current followed by a
tail current as large as that in control. GTx apparently al-
ters voltage-dependent gating of channels while having
little effect on steady-state current activated by very large
depolarizations (Fig. 1, bottom). Although channels can
still be opened by large depolarizations in the presence
of GTx, activation of current is greatly slowed. The ef-
fects of GTx can be interpreted as a powerful stabiliza-
tion of closed states of the channel.
Subsequent addition of CgTx (in the continuing
presence of GTx) blocked the current at 
 
 
 
150 mV as
well as the following tail current (Fig. 1, top right). The
bottom panels of Fig. 1 show the voltage dependence
of current during the test pulse (left) and peak tail cur-
 
rent at 
 
 
 
50 mV after the test pulse (right) in response
to the family of 20-ms voltage steps from 
 
 
 
60 to 
 
 
 
170
mV in control (open circles), GTx (closed circles),
and GTx 
 
 
 
 CgTx (open squares). Addition of CgTx
blocked virtually all current through GTx-bound chan-
nels in three out of three cells.
The additional current inhibition by CgTx suggests
that CgTx can bind to channels already modiﬁed by
GTx. An important consideration in interpreting this
experiment is the time course with which inhibition by
GTx reverses. In principle, if unbinding of GTx was
rapid enough, CgTx could gradually replace GTx at a
hypothetical site capable of binding both toxins. How-
ever, the records in GTx plus CgTx were taken 75–100 s
after addition of CgTx, a period of time during which
there is almost no recovery when GTx is washed out
when applied alone (McDonough et al., 1997a), so that
GTx binding sites would not have become unoccupied
even transiently. (It is very likely that the slow time
course of recovery from GTx represents slow unbind-
Figure 2.  -CTx-MVIIC
blocks N-type channels that
have bound GTx already. N-
type currents were recorded
from a rat sympathetic neu-
ron with an external solution
containing 5  M nimodipine
to block L-type channels.
Open circles, control; closed
circles,  500 nM GTx; open
squares, GTx   1  M  -CTx-
MVIIC. Test pulses with both
toxins present were applied
to the cell starting 80 s after
ﬁrst application of  -CTx-
MVIIC, in the continual pres-
ence of GTx. External solu-
tion: 5 mM BaCl2, 160 mM
TEACl, 10 mM HEPES, pH
7.4 with TEAOH, 5  M nimo-
dipine, 1 mg/ml cytochrome
C. Internal solution: 210 mM
CsOH, 10 mM CsCl, 10 mM
HEPES, 10 mM CsEGTA, 14
mM creatine phosphate (Tris
salt), 4 mM Mg-ATP, and 0.4
mM GTP (Tris salt), pH 7.4
with H3PO4. 22 C. 
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ing of toxin rather than, for example, restricted diffu-
sion from a sequestered extracellular space, because re-
covery of N-type channels from block by 
 
 
 
-CTx-MVIIC,
a peptide of similar size, occurs at least two orders of
magnitude faster.)
 
GTx and 
 
 
 
-CTx-MVIIC:
 
A similar experiment was per-
formed with sequential application of GTx and 
 
 
 
-CTx-
MVIIC (Fig. 2), which, like CgTx, blocks current inde-
pendently of test voltage (McDonough et al., 1996).
Again, 500 nM GTx changed channel gating so that
current at 
 
 
 
20 mV was inhibited, but slow outward cur-
rent and a large inward tail current ﬂowed in response
to a step to 
 
 
 
150 mV (Fig. 2 top, middle). Addition of
 
1 
 
 
 
M 
 
 
 
-CTx-MVIIC in the continued presence of 500
nM GTx inhibited 
 
 
 
80% of this current (Fig. 2 top,
right). Plots of test current and tail current evoked by
voltage steps ranging from 
 
 
 
60 to 
 
 
 
160 mV (Fig. 2,
bottom) show that 
 
 
 
-CTx-MVIIC blocked the great ma-
jority of current activated by strong depolarizations in
the presence of saturating GTx. 
 
 
 
-CTx-MVIIC blocked
essentially all current through GTx-bound channels in
three out of three cells, suggesting that like CgTx,
 
 
 
-CTx-MVIIC bound to a different site on the channel
than GTx. The records in GTx plus 
 
 
 
-CTx-MVIIC were
taken 80–105 s after addition of GTx, so binding of
 
 
 
-CTx-MVIIC does not require unbinding of GTx.
Figure 3. Binding of  -CTx-MVIIC to
N-type channels in rat sympathetic neurons
prevents binding of CgTx. Time course of
inhibition is plotted with each point repre-
senting inward current evoked by a step to
 10 mV from a holding potential of  90
mV. A–C are each from a different cell. (A)
Inhibition by 3  M CgTx (bar) was nearly
irreversible during an hour of washout. (B)
Inhibition by 2  M  -CTx-MVIIC (bar) re-
versed completely within  80 s. (C) Rever-
sal of currents fully inhibited by 2  M
 -CTx-MVIIC (top bars), and then im-
mediately exposed to an additional 1  M
CgTx (ﬁrst bottom bar). The ﬁrst applica-
tion of CgTx came two points after the sec-
ond application of  -CTx-MVIIC, just after
currents had reached steady-state inhibi-
tion. The second application of CgTx (1
 M, second bottom bar), in the absence of
 -CTx-MVIIC, produced irreversible block.
External solution: 5 mM BaCl2, 160 mM
TEACl, 10 mM HEPES, pH 7.4 with
TEAOH, 10  M nimodipine, and 1 mg/ml
cytochrome C. Internal solution (in mM):
108 CsCl, 4 MgCl2, 9 EGTA, 9 HEPES, 4
Mg-ATP, 14 creatine phosphate (Tris salt),
and 0.3 GTP (Tris salt), pH 7.4 with CsOH.
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CgTx and  -CTx-MVIIC. Both CgTx and  -CTx-
MVIIC block currents at all voltages and independent
of preexposure to GTx. Do these two toxins share a
common binding site? A difference in the off-rates of
 -CTx-MVIIC and CgTx from N-type channels was used
to test this. Although both toxins inhibit fully within
seconds, CgTx inhibition is irreversible on the time
scale of tens of minutes (Fig. 3 A; Boland et al., 1994),
whereas  -CTx-MVIIC inhibition reverses fully within
minutes (Fig. 3 B; McDonough et al., 1996). In the ex-
periment shown in Fig. 3 C, current was ﬁrst blocked
with 2  M   -CTx-MVIIC, and the toxin was then
washed out.  -CTx-MVIIC was then applied a second
time and immediately after complete inhibition was
achieved (4 s), 1  M CgTx was applied in the continu-
ing presence of  -CTx-MVIIC. Upon return to control
solution, current recovered almost completely, with the
same fast time course as for the previous washout of
 -CTx-MVIIC applied alone. Subsequent application to
the same cell of CgTx alone blocked the inward cur-
rent quickly and irreversibly (on the time scale of sev-
eral minutes). Apparently, the presence of  -CTx-
MVIIC on the channel prevented CgTx from blocking
currents irreversibly during its ﬁrst application. This
suggests that  -CTx-MVIIC and CgTx compete for
binding to the same site on the channel.
 -Aga-IIIA and CgTx: Unlike the toxins described so
far, inhibition of inward current by saturating concen-
trations of the spider toxin  -Aga-IIIA is only partial,
and inhibition of outward current is minimal (Mintz,
1994). Each point of the time courses in Fig. 4 A repre-
sents average inward barium current from a rat SCG
neuron in response to a depolarizing step to  10 mV.
Channels were inhibited with a saturating concentra-
tion (200 nM) of  -Aga-IIIA and exposed to 3  M
CgTx. CgTx applied for  1 min did not further reduce
the inward current that remained after inhibition by
 -Aga-IIIA. In contrast, CgTx applied alone to a differ-
ent cell inhibited nearly all of the inward current
within 10 s. On average, CgTx applied alone inhibited
90% of the current in rat SCG neurons, whereas the
combination of CgTx added after  -Aga-IIIA inhibited
 70% of the current (Fig. 4 B). Thus, whereas saturat-
ing concentrations of  -Aga-IIIA produce only partial
inhibition of inward current, binding of  -Aga-IIIA pre-
vents the more complete inhibition seen with CgTx
alone. This suggests that  -Aga-IIIA either occupies the
CgTx binding site or binds to the channel in such a way
as to prevent CgTx from reaching its binding site.
With saturating block by  -Aga-IIIA,  30% of the mac-
roscopic current through N-type channels remains. We
know the remaining current is N-type, since it is blocked
by CgTx. The remaining current could represent cur-
rent through N-type channels that did not bind  -Aga-
IIIA, or a partial block of each N-type channel by  -Aga-
Figure 4. Binding of  -Aga-IIIA to N-type channels prevents
block by CgTx. N-type currents were recorded from rat sympa-
thetic neurons with an external solution containing 3  M nimo-
dipine to block L-type channels. Points in time courses represent
steady-state inward currents evoked by a voltage step to  10 mV
from a holding potential of  90 mV. (A) Currents in response to
application of 200 nM  -Aga-IIIA, followed by 3  M CgTx. Times
of toxin application are indicated by the horizontal bars. (B) Cur-
rents from a different cell in response to 3  M CgTx applied at the
time indicated by the horizontal bar. (C) Bar graph comparing the
amount of inward Ba current blocked by  -Aga-IIIA followed by
CgTx (as in A) and by CgTx alone (as in B). Bars represent
mean   SEM for 4–13 experiments. External solution (in mM):
160 TEA-Cl, 5 BaCl2, 10 HEPES, and 0.1 EGTA, plus 1 mg/ml cyto-
chrome C, 3  M tetrodotoxin, and 3  M nimodipine. Internal (pi-
pette) solution (in mM): 108 cesium glutamate, 9 HEPES, 9
EGTA, 4.5 MgCl2, 14 creatine phosphate, 4 Mg-ATP, and 0.3 Tris-
GTP, pH 7.4 with Tris and CsOH. 22 C.319 McDonough et al
IIIA. The second possibility predicts that single-channel
conductance in the presence of saturating concentra-
tions of  -Aga-IIIA would be reduced. To test this predic-
tion, we used nonstationary ﬂuctuation analysis (Sig-
worth, 1980) to estimate single-channel conductance.
Variance was calculated from successive pairs of current
traces elicited by a series of identical voltage steps. Vari-
ance as a function of macroscopic current amplitude was
ﬁt well by a parabolic function; currents in the presence
of 200 nM  -Aga-IIIA were ﬁt by a parabola with shal-
lower rise, corresponding to a homogeneous channel
population with lower conductance than without toxin
(Fig. 5 A). This differs fundamentally from the block
produced by CgTx, where partial block by nonsaturating
concentrations of CgTx does not alter the estimated sin-
gle-channel current (Boland et al., 1994). The estimated
single-channel conductance in  -Aga-IIIA measured
with this method was a roughly linear function of voltage
over the range from  30 to  10 mV, with smaller ampli-
tude than control for all voltages tested (Fig. 5 B). This
suggests that the partial inhibition of N-type current with
saturating concentrations of  -Aga-IIIA is due to a reduc-
tion in single-channel current.
P-Type Channels
P-type calcium channels were recorded from cerebellar
Purkinje neurons, and currents were again assayed af-
ter addition of each toxin. Currents were measured in
the continual presence of 5  M nimodipine and 1  M
CgTx to remove any small contribution from L- or
N-type channels to the total current. With a holding
potential of  80 mV, using an external solution con-
taining 2 mM Ba2  and 160 mM TEA, and with temper-
atures of either 22  or 10 C, T-type current was minimal
(McDonough and Bean, 1998). P-type channels from
cerebellar Purkinje neurons were inhibited by  -CTx-
MVIIC,  -Aga-IIIA, and GTx, as well as by the speciﬁc
blocker  -Aga-IVA. Previous work found that current
through P-type channels is inhibited only partially by
saturating concentrations of  -Aga-IIIA, and that addi-
tion of  -Aga-IVA on top of  -Aga-IIIA produces com-
plete block (Mintz, 1994), suggesting that the two tox-
ins bind to different binding sites. Both  -Aga-IVA and
GTx inhibit P-type channels by shifting the voltage de-
pendence for channel activation strongly in the depo-
larizing direction, so that channels are not activated by
moderate depolarizations. The shifts in voltage depen-
dence produced by GTx and  -Aga-IVA are additive,
suggesting that although they have similar effects on
the channel, the two toxins can bind simultaneously
to the channel (McDonough et al., 1997a). Thus, the
Figure 5. Nonstationary noise analysis of N-type currents during
saturating  -Aga-IIIA block. (A) Variance versus mean current for
a series of currents in control (top) and in 200 nM  -Aga-IIIA (bot-
tom) elicited in a 5-mM Ba extracellular solution containing 10
 M nimodipine. Macroscopic current from this cell was blocked
75% by  -Aga-IIIA. Ensembles of currents were generated by a se-
ries of identical voltage pulses from  90 to  10 mV delivered ev-
ery 2 s. Data were sampled at 20  s after ﬁltering at 3 kHz (4-pole
Bessel). The variance at each time point was calculated for each
pair of pulses in a series, and then averaged over the pairs for each
series. Background variance at the holding potential was sub-
tracted from the variance during the test pulse. Smooth lines are
best ﬁts (least-squares) to the equation (Sigworth, 1980) vari-
ance   iI  I2/N, where I is the mean current, n is the number of
channels, and i is the unitary current. For control, ﬁt shown is i  
0.25 pA, N   40,615. In  -Aga-IIIA, ﬁt shown is i   0.14 pA, N  
40,615. (B) Effect of  -Aga-IIIA on single-channel current ampli-
tude as a function of test potential from  30 to  20 mV. Open cir-
cles, control; closed circles,    -Aga-IIIA. The single-channel con-
ductance ( ) is estimated from the slope of a line ﬁt by linear re-
gression to the data from  30 to  10 mV. Points represent
means   SEM for three to ﬁve experiments.320 Multiple Toxin Binding Sites on Neuronal Calcium Channels
pies the  -CTx-MVIIC binding site or prevents it from
binding.
 -CTx-MVIIC and  -Aga-IVA.  We tested for additive
binding of  -Aga-IVA and  -CTx-MVIIC by making use
of the different voltage dependence of block by the two
toxins. Although  -Aga-IVA produced almost complete
inhibition of inward currents elicited by a test pulse to
 20 mV (Fig. 7 A), a 15-ms step to  30 mV evoked in-
ward current followed by a larger tail current at a volt-
age of  60 mV (Fig. 7 B, right). This is consistent
with previous studies showing a depolarizing shift in
the voltage dependence of channels with  -Aga-IVA
bound, so that depolarization to  30 mV, but not  20
mV, opens a signiﬁcant fraction of the channels (Mc-
Donough et al., 1997b). Using tail current at  60 mV
after a test pulse to  30 mV to elicit current in the pres-
ence of  -Aga-IVA, application of  -CTx-MVIIC pro-
duced rapid inhibition of both test pulse current and
the tail current (Fig. 7 B, left). The 15-ms pulse to  30
 -Aga-IVA binding site appears to be separate from the
binding sites for both  -Aga-IIIA and GTx. We tested
for overlapping binding sites on P-type channels among
 -CTx-MVIIC and these three toxins.
 -CTx-MVIIC and  -Aga-IIIA. We ﬁrst tested for in-
teractions between the binding of  -CTx-MVIIC and
 -Aga-IIIA.  -Aga-IIIA was applied ﬁrst and, as expected,
blocked the inward current only partially (Fig. 6 A;
Mintz, 1994). Subsequent addition of  -CTx-MVIIC
had no effect (Fig. 6 A) even though  -CTx-MVIIC
applied alone at the same concentration produces
complete inhibition of the inward current (see Fig. 9).
 -CTx-MVIIC applied after  -Aga-IIIA also had no ef-
fect on the outward currents elicited by steps positive to
the reversal potential near  80 mV (Fig. 6 B), although
this current is effectively blocked by  -CTx-MVIIC ap-
plied alone (McDonough et al., 1996). Addition of
 -CTx-MVIIC applied after  -Aga-IIIA had no effect in
ﬁve out of ﬁve cells. Evidently  -Aga-IIIA either occu-
Figure 6. Binding of  -Aga-IIIA to P-type chan-
nels prevents block by  -CTx-MVIIC. (A) P-type
current was elicited in a Purkinje neuron by 65-ms
test pulses to  20 mV from a holding potential of
 80 mV; tail currents were measured at  80 mV.
(top) Traces taken in control, after maximal inhi-
bition by 200 nM  -Aga-IIIA, and 30 s after addi-
tion of 10  M  -CTx-MVIIC (in the continued
presence of 200 nM  -Aga-IIIA). (bottom) Time
course of inhibition. (B) Current-voltage relation-
ships for current in control (open circles), in 200
nM  -Aga-IIIA (up triangles), and in 200 nM
 -Aga-IIIA   10  M  -CTx-MVIIC (down trian-
gles) in response to a 15-ms depolarization to the
indicated voltage from a holding voltage of  80
mV. External solution: 2 mM BaCl2, 160 mM
TEACl, 10 mM HEPES (pH adjusted to 7.4 with
TEAOH), 0.6  M tetrodotoxin, 5  M nimo-
dipine, 1  M  -conotoxin GVIA, and 1 mg/ml cy-
tochrome C. Internal solution: 56 mM CsCl, 68
mM CsF, 2.2 mM MgCl2, 4.5 mM EGTA, 9 mM
HEPES, 4 mM MgATP, 14 mM creatine phos-
phate (Tris salt), and 0.3 mM GTP (Tris salt), pH
adjusted to 7.4 with CsOH. To correct for small
noncalcium channel currents, currents remain-
ing in 600  M CdCl2 were subtracted. 22 C.321 McDonough et al
mV was not sufﬁciently strong to induce  -Aga-IVA dis-
sociation from the channel (McDonough et al., 1997b),
suggesting that the inhibition of tail currents reﬂects
additional, and not substitutive, binding of  -CTx-
MVIIC. Additional inhibition by  -CTx-MVIIC was seen
at all test voltages. Fig. 7 C shows the peak tail current
evoked by each of a family of 20-ms depolarizations to
the indicated voltage in control (Fig. 7 C, open circles),
after maximal inhibition by 400 nM  -Aga-IVA (Fig. 7
C, closed circles), and after subsequent addition of 10
 M  -CTx-MVIIC (Fig. 7 C, open squares). Addition of
 -CTx-MVIIC inhibited almost all the outward current
Figure 7.  -CTx-MVIIC
blocks P-type channels ex-
posed to saturating  -Aga-
IVA. (A) Inhibition by 400
nM  -Aga-IVA of current elic-
ited by 30-ms steps from  80
to   20 mV. (left) Time
course of inhibition. (right)
Currents in control and after
complete inhibition by  -Aga-
IVA. After the 30-ms step
from   80 to  20 mV, the
voltage was repolarized to
 60 mV. (B) Block by 10  M
 -CTx-MVIIC of the P-type
current elicited by a large de-
polarization in the presence
of 400 nM  -Aga-IVA. Cur-
rents were elicited by 15-ms
steps to  30 mV, followed by
tail currents at  60 mV. Both
the small inward current at
 30 mV and the much larger
tail current at  60 mV were
blocked by the addition of 10
 M  -CTx-MVIIC to 400 nM
 -Aga-IVA. (left) Time course
of additional inhibition by 10
 M  -CTx-MVIIC in the con-
tinual presence of 400 nM
 -Aga-IVA. Currents were
evoked every 5 s. (right) Cur-
rents in  -Aga-IVA and 50 s af-
ter addition of 10  M  -CTx-
MVIIC. (C) Tail currents at
 60 mV after a 20-ms depo-
larization to the indicated
voltage in control (open cir-
cles), 400 nM  -Aga-IVA
(closed circles), and  -Aga-
IVA    10  M   -CTx-MVIIC
(open squares). Currents re-
maining in 500  M CdCl2
were subtracted. The slight
increase in current from  40
to   120 mV in  -Aga-IVA
may reﬂect dissociation of
toxin from the channel in-
duced by repetitive depolar-
izations. After taking the tail
current activation curve in
 -Aga-IVA, data acquisition
was paused to allow full rebinding of  -Aga-IVA, before beginning acquisition again for the experiment of B. Scale bars are 1 nA (vertical)
and 10 ms (horizontal). External solution: 2 mM BaCl2, 160 mM TEACl, 10 mM HEPES (pH adjusted to 7.4 with TEAOH), 0.6  M tetro-
dotoxin, 5  M nimodipine, 1  M  -conotoxin GVIA, and 1 mg/ml cytochrome C. Internal solution (in mM): 56 CsCl, 68 CsF, 2.2 MgCl2,
4.5 EGTA, 9 HEPES, 4 MgATP, 14 creatine phosphate (Tris salt), and 0.3 GTP (Tris salt), pH adjusted to 7.4 with CsOH. To correct for
small noncalcium channel currents, currents remaining in 600  M CdCl2 were subtracted. 22 C.322 Multiple Toxin Binding Sites on Neuronal Calcium Channels
and tail current that remained in  -Aga-IVA. In three
cells studied with this protocol,  -CTx-MVIIC inhibited
74% of the outward current and 93% of the inward tail
current evoked by a depolarization to  150 mV in
 -Aga-IVA. The remaining outward current could be
due to some voltage dependence of  -CTx-MVIIC inhi-
bition that occurs only in the presence of  -Aga-IVA,
but is more likely a small current carried by intracellu-
lar cesium through channels other than calcium chan-
nels. The simplest interpretation is that  -CTx-MVIIC
effectively blocks currents through channels with gat-
ing altered by bound  -Aga-IVA.
 -CTx-MVIIC and GTx.  Fig. 8 shows currents from a
Purkinje neuron exposed to ﬁrst 800 nM GTx (Fig. 8
top, middle) and then to GTx   5  M  -CTx-MVIIC
(Fig. 8 top, right). For each condition, currents are
shown in response to depolarizations to –10 mV and
 150 mV, with tail currents measured at –60 mV. The
depolarization to  150 mV in control (Fig. 8 top, left)
resulted in a transient phase of outward current and in
a slow, sigmoidally decaying tail current; these are due
not to poor space clamp, but to an additional open
state of the native rat P-type channel reached via strong
depolarizations (McDonough et al., 1997b; McFarlane,
1997). GTx produced full inhibition of current at  10
mV, but just as for GTx action on N-type currents, chan-
nels could still be activated by sufﬁciently large depolar-
izations, though with greatly slowed kinetics. Depolar-
ization to  150 mV elicited a slow outward current, fol-
lowed by a large tail current at  60 mV. Subsequent
application of  -CTx-MVIIC blocked virtually all cur-
rent. Graphs at bottom display the amplitudes of the
test current (Fig. 8, left) and the inward tail current
(Fig. 8, right) at test voltages from  70 to  160 mV.
Current through GTx-bound channels (Fig. 8, closed
circles) was completely removed by  -CTx-MVIIC (Fig.
8, open squares; records shown were taken 160 s after
ﬁrst application of  -CTx-MVIIC, not enough time for
GTx to unbind appreciably at this temperature). Evi-
dently  -CTx-MVIIC blocks current through channels
after alteration of gating by GTx.
 -CTx-MVIIC and Cd2 .  Does  -CTx-MVIIC produce
channel inhibition by directly blocking the pore of the
channel? This possible mechanism was addressed by
testing for interaction of  -CTx-MVIIC block with that
produced by Cd2 . The divalent selectivity of calcium
channels is believed to depend on a high afﬁnity
calcium binding site near the external mouth of the
channel pore (Kuo and Hess, 1993) formed by four
glutamate residues (Yang et al., 1993; Wu et al., 2000).
The block of calcium channels by Cd2  likely results
from high afﬁnity binding to this site. Seven of the 26
residues in the amino acid sequence of  -CTx-MVIIC
are positively charged. A reasonable hypothesis is that
 -CTx-MVIIC occludes the pore via direct interaction of
a positively charged toxin residue with one or more
glutamate residues of the pore, similar to block of Shaker
K  channels by charybdotoxin (Ranganathan et al.,
1996; Naranjo and Miller, 1996). The on-rate and afﬁn-
ity of  -CTx-MVIIC for the channel decreases dramati-
cally with increasing concentration of divalent charge
carrier, more than expected for surface charge screen-
ing alone (McDonough et al., 1996), which is consistent
with an interaction between  -CTx-MVIIC and ion bind-
ing sites. Calcium channels can be blocked by micromo-
lar concentrations of external Cd2 , which is believed to
act by binding very tightly to glutamate residues within
the pore (Yang et al., 1993). If the  -CTx-MVIIC bind-
ing site involves this same site, toxin block might be dif-
ferent in the presence or absence of Cd2 . To test for
such an interaction, the kinetics of inhibition of P-type
currents by 5  M   -CTx-MVIIC were measured with
and without preblock by 1  M Cd2  (Fig. 9). The off-
rate of Cd2  is fast,  1,000 s 1 (Lansman et al., 1986;
Sah and Bean, 1994), so in 1  M Cd2 , channels are in
rapid equilibrium between states with and without Cd2 
occupancy at the high afﬁnity binding sites. In control,
the onset of  -CTx-MVIIC inhibition in control was de-
scribed well by a single exponential function with a time
constant of 19 s. In the presence of 1  M Cd2 , which
blocked current to 80%, the kinetics of block by  -CTx-
MVIIC were identical to those in control. When this
experiment was repeated in multiple cells, averaged  
values were 19   2 s (mean   SEM, n   6) for  -CTx-
MVIIC alone, and 20   1 s (n   5) for  -CTx-MVIIC
applied in the presence of 1  M Cd2 . Apparently the
 -CTx-MVIIC on rate is not inﬂuenced by Cd2  occu-
pancy of Ca2 -binding sites.
DISCUSSION
There is currently no picture of the mechanism by
which a calcium channel-blocking toxin docks to the
channel protein comparable in detail to that achieved
for potassium channel-blocking toxins such as agitoxin
and charybdotoxin (Goldstein et al., 1994; Gross and
MacKinnon, 1996). We can develop a working model
for the different toxins, however, making use of our re-
sults together with previous data, including binding ex-
periments with radiolabeled toxins and experiments
examining interactions of toxins with mutant channels.
A summary of the interactions of different toxins is
shown in Table I. 
A useful ﬁrst-order distinction can be made based on
whether toxins inhibit inward calcium channel current
by altering the voltage dependence of channel gating or
by blocking the channel pore directly. Previous experi-
ments showed that GTx blocks inward current by shift-
ing the voltage dependence of channel gating by 85–100
mV in the depolarizing direction, so that toxin-modiﬁed323 McDonough et al
Figure 8.  -CTx-MVIIC blocks P-type
channels exposed to saturating GTx.
(top) Inward and outward currents
evoked by a 15-ms test pulse to  10 and
 150 mV from a holding potential of
 80 mV, followed by tail currents at
 60 mV, in control (left), after maxi-
mal inhibition by 800 nM GTx (mid-
dle), and 160 s after addition of 5  M
 -CTx-MVIIC, in the continual pres-
ence of GTx (right). (bottom) Test cur-
rents (left) and tail currents at  60 mV
(right) after a 15-ms step to the indi-
cated test voltage. Open circles, control;
closed circles,  800 nM GTx; open
squares, GTx   5  M   -CTx-MVIIC.
External solution: 2 mM BaCl2, 160 mM
TEACl, 10 mM HEPES (pH adjusted to
7.4 with TEAOH), 0.6  M tetrodotoxin,
5   M nimodipine, 1  M   -conotoxin
GVIA, and 1 mg/ml cytochrome C. In-
ternal solution (in mM): 56 CsCl, 68
CsF, 2.2 MgCl2, 4.5 EGTA, 9 HEPES, 4
MgATP, 14 creatine phosphate (Tris
salt), and 0.3 GTP (Tris salt), pH ad-
justed to 7.4 with CsOH. To correct for
small noncalcium channel currents,
currents remaining in 600  M CdCl2
were subtracted. Experiment per-
formed at 10 C to slow tail kinetics.
Figure 9. On-rate of inhibition of
P-type channels by  -CTx-MVIIC in the
presence of 1  M Cd2 . Time course of
inhibition of inward current by 5  M
 -CTx-MVIIC, alone (left) and after
preblock by 1  M Cd2  (right). Each
point represents steady-state inward
current from a 65-ms test pulse to  10
mV from a holding voltage of  80 mV.
Data are from two separate cells. Solid
lines are single exponential functions
with the indicated time constant. Exter-
nal solution: 2 mM BaCl2, 160 mM
TEACl, 10 mM HEPES (pH adjusted to
7.4 with TEAOH), 0.6  M tetrodotoxin,
5   M nimodipine, 1  M   -conotoxin
GVIA, and 1 mg/ml cytochrome C. In-
ternal solution (in mM): 56 CsCl, 68
CsF, 2.2 MgCl2, 4.5 EGTA, 9 HEPES, 4
MgATP, 14 creatine phosphate (Tris
salt), and 0.3 GTP (Tris salt), pH ad-
justed to 7.4 with CsOH. 22 C.324 Multiple Toxin Binding Sites on Neuronal Calcium Channels
channels are no longer opened by depolarization to
physiological voltages (McDonough et al., 1997a; Bouri-
net et al., 2001). Permeation properties of open chan-
nels were not affected. GTx produces a similar shift of N-
and P-type gating, suggesting a similar binding site for
both channels. GTx also shifts the gating of some volt-
age-dependent potassium channels, although the shift is
weaker and the toxin potency orders of magnitude lower
(Kd   19  M for each of four presumptive toxin binding
sites; Li-Smerin and Swartz, 1998). Point mutations in
the extracellular loop linking the third (S3) and fourth
(S4) transmembrane segments of the potassium channel
subunit lowered this afﬁnity further. This suggests that
GTx binding to calcium channels may involve the S3-S4
linker of one or more of the four pseudosubunits of the
  subunit. However, there is no direct evidence for this,
nor any information about how many GTx molecules
can bind to the channel.
 -Aga-IVA also inhibits calcium channels by shifting
the voltage dependence of activation strongly in the de-
polarizing direction without affecting permeation (Mc-
Donough et al., 1997b). However, it seems clear that
the binding epitope (or epitopes) for  -Aga-IVA is dif-
ferent from that of GTx. First, unlike GTx,  -Aga-IVA
has very little effect on N-type channels except at mi-
cromolar concentrations (Sidach and Mintz, 2000).
Second, on P-type channels, the voltage shifts pro-
duced by saturating concentrations of GTx and  -Aga-
IVA are additive, suggesting that both toxins can bind
simultaneously (McDonough et al., 1997a). Although
the binding site for  -Aga-IVA also is not known, the af-
ﬁnity of the expressed  1A (P-type) channel for  -Aga-
IVA is affected by deletion or insertion of two amino
acid residues in the S3-S4 linker of domain IV (Bouri-
net et al., 1999; Hans et al., 1999). If the binding sites
for both GTx and  -Aga-IVA each involve an S3-S4
linker, the apparent lack of interaction between the two
toxins indicates that either they bind to the S3-S4 link-
ers of different pseudosubunits or to different regions
of the same linker.
CgTx,  -Aga-IIIA, and  -CTx-MVIIC all inhibit N-type
channels through a mechanism different than alter-
ation of channel gating, possibly through pore block-
ade. Both CgTx and  -CTx-MVIIC produce complete
block of both inward and outward currents for both
moderate and large depolarizations. The simplest possi-
bility is that these toxins bind tightly to the outer mouth
of the channel and physically block the pore in a man-
ner that is not affected by channel gating. However, on
the basis of voltage dependence of block alone, it is im-
possible to distinguish pore blockade from a shift of
channel gating to such depolarized voltages that pulses
to about  150 mV do not open the channel. Further ev-
idence points to blockade of the pore by CgTx. Muta-
tions in extracellular loops between S5 and the pore-
forming region affect the kinetics of CgTx block, consis-
tent with toxin binding near the external mouth of the
pore (Ellinor et al., 1994), and the potency of CgTx
block is affected by the species and concentration of
permeant ions (Boland et al., 1994). Neither of these
experiments is entirely deﬁnitive, however, as only toxin
kinetics, not afﬁnity, for mutant channels was assayed
and as high divalent cation concentrations could inter-
fere with the channel itself. There is also evidence that
several of these toxins exert allosteric effects on channel
structure when they bind (Stocker et al., 1997; Yan and
Adams, 2002) and so might couple allosterically to some
constriction of the pore.
Whatever the exact mechanism of channel inhibition
by CgTx and  -CTx-MVIIC, our results show that the
two inhibit current by binding at the same (or at least
overlapping) sites, since  -CTx-MVIIC binding pre-
vented CgTx block. If CgTx indeed blocks the pore,
this implies that  -CTx-MVIIC does as well. CgTx bind-
ing to N-type channels also is prevented by  -Aga-IIIA.
However, block by  -Aga-IIIA is different from that by
CgTx and  -CTx-MVIIC in that saturating concentra-
tions produce only partial block. Our results using
noise analysis suggest that the current remaining in
 -Aga-IIIA represents current through channels whose
conductance has been reduced but not eliminated by
 -Aga-IIIA. The simplest possibility is that  -Aga-IIIA
acts as a leaky lid near the outside of the pore that re-
duces, but does not eliminate, current ﬂow. Consistent
TABLE I
Summary of Electrophysiological Properties of Toxins Studied
Toxin
Channel
type
Likely
mechanism
of inhibition
Toxins with
independent
effects
Toxins with non
independent
effects
CgTx N pore block
(complete)
GTxa  -Aga-IIIAa, 
 -CTx-MVIICa
 -Aga-IVA P shift of 
activation
GTxa,  -CTx-
MVIICa,
 -Aga-IIIA
 -CTx-MVIIC N pore block
(complete)
GTxa CgTxa
P pore block
(complete)
GTxa,
 -Aga-IVAa
 -Aga-IIIAa
 -Aga-IIIA N pore block
(partial)
 -CTx-MVIICa,
CgTxa
P pore block
(partial)
 -Aga-IVA  -CTx-MVIICa
GTx N shift of 
activation
CgTxa, 
 -CTx-MVIICa
P shift of 
activation
 -Aga-IVA, 
 -CTx-MVIICa
aConclusions from this study.
Information in table also draws on data from Mintz et al., 1991; Boland et
al., 1994; Ellinor et al., 1994; Mintz, 1994; McDonough et al., 1996, 1997a,b;
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with this, the current through channels bound to
 -Aga-IIIA can no longer be blocked by the putative pore-
blockers CgTx and  -CTx-MVIIC.  -Aga-IIIA is a much
larger peptide than either CgTx or  -CTx-MVIIC, and
it might ﬁt less tightly within the pore vestibule, and so
itself produce incomplete block of ion ﬂow itself while
completely eliminating access by CgTx and  -CTx-
MVIIC. Taken together, results suggest that  -CTx-
MVIIC,   -Aga-IIIA, and CgTx all inhibit current by
blocking the channel pore, whether directly or through
binding sites that couple allosterically.
For  -CTx-MVIIC block of P-type channels, we found
that the kinetics of block were not inﬂuenced by the
presence or absence of 1  M Cd2 , which produced
 80% block. This is very similar to previous results
checking for an interaction between CgTx and Cd2 
block of N-type calcium channels (Boland et al., 1994).
In principle, if Cd2  and CgTx (or  -CTx-MVIIC) both
bind to the external mouth of the pore, they might show
kinetic interactions. However, the lack of apparent inter-
action can still be consistent with a pore blocking mecha-
nism for the toxins. In normal solutions, the binding site
formed by the four glutamate residues making up the se-
lectivity ﬁlter of the calcium channel (Yang et al., 1993)
presumably has at least one calcium ion bound at all
times. Cd2  and Ca2  bound to this site might present
equivalent effects on a toxin molecule, which might bind
equally effectively when the site is occupied by either di-
valent ion. Alternatively, the toxin might occlude the
pore without interacting with the selectivity ﬁlter.
Our results on toxin interactions in inhibiting cal-
cium channels can be compared with previous experi-
ments using the binding of radiolabeled toxins to
membrane fractions. The two approaches complement
each other well: direct measurements of toxin–channel
binding can be performed on a slower time scale with
much lower concentrations of toxin, whereas electro-
physiological experiments on single cells, which mea-
sure toxin-induced inhibition of current rather than
biochemical binding directly, can be done with un-
wanted channel types already blocked and with chan-
nels in known gating states. This avoids complications
from membrane preparations containing mixtures of
channel types or with channels in different gating
states. The latter is an important consideration when
using toxins with state-dependent afﬁnity.
The prevention of CgTx block by  -Aga-IIIA is consis-
tent with binding experiments, in which  -Aga-IIIA
prevented  90% of CgTx binding to membranes from
rat and chick brain or from bovine chromafﬁn cells
(McIntosh et al., 1992; Venema et al., 1992; Adams et
al., 1993; Ertel et al., 1994). Low  -Aga-IIIA concentra-
tions also potently inhibit radiolabeled  -CTx-MVIIC
binding to rat brain membranes (Adams et al., 1993).
These results indicate that  -CTx-MVIIC cannot bind
to N- or P-type channels already bound to  -Aga-IIIA,
exactly as we found. Interestingly, however, the reverse
binding experiment gave an opposite result: binding of
radiolabeled   -Aga-IIIA to rat brain membranes was
much less affected by binding of CgTx or of  -CTx-
MVIIC (Adams et al., 1993). (This reverse experiment
could not be done by measuring currents, since initial
application of CgTx to N-type or of  -CTx-MVIIC to
P-type channels would inhibit all current irreversibly.)
Apparently, once CgTx or  -CTx-MVIIC is on its bind-
ing site,  -Aga-IIIA can still make contact and bind to
the channel. If CgTx indeed binds within the pore ves-
tibule,  -Aga-IIIA may bind on top of the CgTx–chan-
nel complex, further away from the pore than CgTx.
Consistent with this,  -Aga-IIIA dramatically slows the
dissociation of labeled CgTx that has been previously
bound to the channel (Yan and Adams, 2002), but not
vice versa. Binding of  -Aga-IIIA at the outer part of the
pore vestibule also ﬁts with the decrease in single-chan-
nel current caused by  -Aga-IIIA, although our data do
not distinguish this from the allosteric model proposed
by Yan and Adams (2002).
The prevention of CgTx block of N-type currents by
 -CTx-MVIIC (Fig. 3) also is supported by biochemi-
cal measurements.  -CTx-MVIIC competed efﬁciently
(IC50   1–10 nM) with radiolabeled CgTx for binding
to rat brain membranes (Hillyard et al., 1992), and
(somewhat less efﬁciently) to membranes from adrenal
medulla (Gandia et al., 1997). The effectiveness of low
 -CTx-MVIIC concentrations in these experiments sug-
gests that similarly low concentrations would also pre-
vent inhibition of current by CgTx (Fig. 3), although
an individual toxin may have additional binding sites
on the channel that do not necessarily block channel
current. In the reverse experiment, even 1  M CgTx
did not inhibit  -CTx-MVIIC binding to membranes
from bovine brain cortex (Gandia et al., 1997). CgTx
inhibition of  -CTx-MVIIC binding to rat brain mem-
branes also was weak (Hillyard et al., 1992), although
binding of  -CTx-MVIIC to P/Q-type as well as N-type
channels may contribute to this effect. We conclude
that CgTx and  -CTx-MVIIC inhibit current by binding
at the same site, further evidence that  -CTx-MVIIC in-
hibits current by blocking the channel pore.
The picture for GTx is somewhat simpler: currents
through channels bound to GTx are inhibited by
 -CTx-MVIIC and by CgTx. This is consistent with
binding experiments in which GTx fully blocked 45Ca2 
inﬂux into chick synaptosomes, but failed to displace
CgTx binding (Lampe et al., 1993). The GTx binding
site appears distinct from that of all the other toxins de-
scribed, implying that it is not within the pore. GTx
may bind to more than one site, as GTx inhibition of
native P-type channels reverses with complex, nonexpo-
nential kinetics (McDonough et al., 1997a).326 Multiple Toxin Binding Sites on Neuronal Calcium Channels
In the initial description of  -CTx-MVIIC, Hillyard et
al. (1992) found that  -Aga-IVA failed to compete with
radiolabeled   -CTx-MVIIC for binding to rat brain
membrane preparations. These results implied that
 -Aga-IVA and  -CTx-MVIIC targeted either subpopu-
lations of channels or different binding sites on the same
channel. Results presented here on isolated P-type
channels support the latter conclusion. However, when
the binding experiment is done in the reverse direc-
tion,   -CTx-MVIIC at concentrations  1   M,   500
times its half-maximal binding concentration, com-
petes with radiolabeled  -Aga-IVA for binding to rat
brain membranes, with complete displacement at  5
 M (Adams et al., 1993). Either  -CTx-MVIIC binding
allosterically destabilizes  -Aga-IVA binding, or  -CTx-
MVIIC has a low afﬁnity site that inﬂuences  -Aga-IVA
binding, in addition to a high afﬁnity site. The possibil-
ity of more than one binding site for  -CTx-MVIIC also
was hinted at by small discrepancies between half-maxi-
mal blocking concentrations and the dissociation con-
stant of  -CTx-MVIIC calculated from toxin on- and
off-rates on N-type channels (McDonough et al., 1996).
The existence of multiple binding sites for toxins on
both N- and P-type calcium channels suggests the possi-
bility of developing small molecule pharmacological
agents acting by distinct mechanisms, either by modu-
lating gating or by physically occluding the channel.
For both mechanisms, there are toxins that are selec-
tive between N- and P-type channels, which is likely to
be a key consideration in developing useful pharmaco-
logical agents. The successful use of intrathecal injec-
tions of the cone snail toxin ziconitide ( -conotoxin
MVIIA) to treat pain in both rats (Wang et al., 2000)
and humans (Jain, 2000) already has shown that block-
ers of N-type channels have pharmacological utility. Im-
proved understanding of binding sites and mechanisms
of channel inhibition by other toxins should help in
the development of small molecules that mimic the ef-
fects of the toxins.
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